Dr. Martens plc (FRA:3U2)

Dr. Martens Statistics

Total Valuation

Dr. Martens has a market cap or net worth of EUR 947.16 million. The enterprise value is 1.23 billion.

Market Cap	947.16M
Enterprise Value	1.23B

Important Dates

The next estimated earnings date is Thursday, November 20, 2025.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	Aug 28, 2025

Share Statistics

Current Share Class	966.41M
Shares Outstanding	n/a
Shares Change (YoY)	-1.17%
Shares Change (QoQ)	+6.06%
Owned by Insiders (%)	0.99%
Owned by Institutions (%)	51.42%
Float	517.89M

Valuation Ratios

The trailing PE ratio is 176.11 and the forward PE ratio is 19.84.

PE Ratio	176.11
Forward PE	19.84
PS Ratio	1.01
PB Ratio	2.16
P/TBV Ratio	8.58
P/FCF Ratio	4.22
P/OCF Ratio	4.04
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.51, with an EV/FCF ratio of 5.47.

EV / Earnings	228.53
EV / Sales	1.37
EV / EBITDA	8.51
EV / EBIT	17.83
EV / FCF	5.47

Financial Position

The company has a current ratio of 2.59, with a Debt / Equity ratio of 1.10.

Current Ratio	2.59
Quick Ratio	1.37
Debt / Equity	1.10
Debt / EBITDA	3.18
Debt / FCF	2.15
Interest Coverage	2.01

Financial Efficiency

Return on equity (ROE) is 1.23% and return on invested capital (ROIC) is 4.70%.

Return on Equity (ROE)	1.23%
Return on Assets (ROA)	4.12%
Return on Invested Capital (ROIC)	4.70%
Return on Capital Employed (ROCE)	8.30%
Revenue Per Employee	400,887
Profits Per Employee	2,290
Employee Count	2,348
Asset Turnover	0.86
Inventory Turnover	1.25

Taxes

In the past 12 months, Dr. Martens has paid 5.14 million in taxes.

Income Tax	5.14M
Effective Tax Rate	48.86%

Stock Price Statistics

The stock price has increased by +54.26% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+54.26%
50-Day Moving Average	1.02
200-Day Moving Average	0.83
Relative Strength Index (RSI)	41.41
Average Volume (20 Days)	78

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Martens had revenue of EUR 941.28 million and earned 5.38 million in profits. Earnings per share was 0.01.

Revenue	941.28M
Gross Profit	611.55M
Operating Income	72.54M
Pretax Income	10.52M
Net Income	5.38M
EBITDA	90.47M
EBIT	72.54M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 186.32 million in cash and 482.95 million in debt, giving a net cash position of -296.63 million.

Cash & Cash Equivalents	186.32M
Total Debt	482.95M
Net Cash	-296.63M
Net Cash Per Share	n/a
Equity (Book Value)	437.89M
Book Value Per Share	0.45
Working Capital	301.53M

Cash Flow

In the last 12 months, operating cash flow was 234.60 million and capital expenditures -10.04 million, giving a free cash flow of 224.56 million.

Operating Cash Flow	234.60M
Capital Expenditures	-10.04M
Free Cash Flow	224.56M
FCF Per Share	n/a

Margins

Gross margin is 64.97%, with operating and profit margins of 7.71% and 0.57%.

Gross Margin	64.97%
Operating Margin	7.71%
Pretax Margin	1.12%
Profit Margin	0.57%
EBITDA Margin	9.61%
EBIT Margin	7.71%
FCF Margin	23.86%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.00%.

Dividend Per Share	0.03
Dividend Yield	3.00%
Dividend Growth (YoY)	0.20%
Years of Dividend Growth	n/a
Payout Ratio	211.11%
Buyback Yield	1.17%
Shareholder Yield	4.17%
Earnings Yield	0.57%
FCF Yield	23.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dr. Martens has an Altman Z-Score of 4.97 and a Piotroski F-Score of 7.

Altman Z-Score	4.97
Piotroski F-Score	7